Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
This compound is part of our Peptides research category, which includes a range of laboratory-grade peptide compounds studied in controlled environments
Treatment with tunicamycin (TM), an N-glycosylation inhibitor, in combination with gemcitabine significantly reduces the viability of PANC-1 cells, suggesting that targeting the N-glycosylation pathway holds promise for combination therapy in PDAC [157]
Mann JFE, Rossing P, Bakris G, Belmar N, Bosch-Traberg H, Busch R, et al
So, I stopped the harmful vices that were affecting my life
US$ 26.71
US$ 23.02
US$ 28.23
US$ 25.18
